List of Tables
Table 1. Global Vidarabine Monophosphate for Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Vidarabine Monophosphate for Injection Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Vidarabine Monophosphate for Injection Market Competitive Situation by Manufacturers in 2024
Table 4. Global Vidarabine Monophosphate for Injection Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Vidarabine Monophosphate for Injection Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Vidarabine Monophosphate for Injection Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Vidarabine Monophosphate for Injection Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Vidarabine Monophosphate for Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Vidarabine Monophosphate for Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Vidarabine Monophosphate for Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Vidarabine Monophosphate for Injection, Product Type & Application
Table 12. Global Key Manufacturers of Vidarabine Monophosphate for Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Vidarabine Monophosphate for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vidarabine Monophosphate for Injection as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Vidarabine Monophosphate for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Vidarabine Monophosphate for Injection Sales by Region (2020-2025) & (K Units)
Table 18. Global Vidarabine Monophosphate for Injection Sales Market Share by Region (2020-2025)
Table 19. Global Vidarabine Monophosphate for Injection Sales by Region (2026-2031) & (K Units)
Table 20. Global Vidarabine Monophosphate for Injection Sales Market Share by Region (2026-2031)
Table 21. Global Vidarabine Monophosphate for Injection Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Vidarabine Monophosphate for Injection Revenue Market Share by Region (2020-2025)
Table 23. Global Vidarabine Monophosphate for Injection Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Vidarabine Monophosphate for Injection Revenue Market Share by Region (2026-2031)
Table 25. North America Vidarabine Monophosphate for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Vidarabine Monophosphate for Injection Sales by Country (2020-2025) & (K Units)
Table 27. North America Vidarabine Monophosphate for Injection Sales by Country (2026-2031) & (K Units)
Table 28. North America Vidarabine Monophosphate for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Vidarabine Monophosphate for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Vidarabine Monophosphate for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Vidarabine Monophosphate for Injection Sales by Country (2020-2025) & (K Units)
Table 32. Europe Vidarabine Monophosphate for Injection Sales by Country (2026-2031) & (K Units)
Table 33. Europe Vidarabine Monophosphate for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Vidarabine Monophosphate for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Vidarabine Monophosphate for Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Vidarabine Monophosphate for Injection Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Vidarabine Monophosphate for Injection Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Vidarabine Monophosphate for Injection Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Vidarabine Monophosphate for Injection Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Vidarabine Monophosphate for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Vidarabine Monophosphate for Injection Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Vidarabine Monophosphate for Injection Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Vidarabine Monophosphate for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Vidarabine Monophosphate for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Vidarabine Monophosphate for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Vidarabine Monophosphate for Injection Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Vidarabine Monophosphate for Injection Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Vidarabine Monophosphate for Injection Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Vidarabine Monophosphate for Injection Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Vidarabine Monophosphate for Injection Sales (K Units) by Type (2020-2025)
Table 51. Global Vidarabine Monophosphate for Injection Sales (K Units) by Type (2026-2031)
Table 52. Global Vidarabine Monophosphate for Injection Sales Market Share by Type (2020-2025)
Table 53. Global Vidarabine Monophosphate for Injection Sales Market Share by Type (2026-2031)
Table 54. Global Vidarabine Monophosphate for Injection Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Vidarabine Monophosphate for Injection Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Vidarabine Monophosphate for Injection Revenue Market Share by Type (2020-2025)
Table 57. Global Vidarabine Monophosphate for Injection Revenue Market Share by Type (2026-2031)
Table 58. Global Vidarabine Monophosphate for Injection Price (US$/Unit) by Type (2020-2025)
Table 59. Global Vidarabine Monophosphate for Injection Price (US$/Unit) by Type (2026-2031)
Table 60. Global Vidarabine Monophosphate for Injection Sales (K Units) by Application (2020-2025)
Table 61. Global Vidarabine Monophosphate for Injection Sales (K Units) by Application (2026-2031)
Table 62. Global Vidarabine Monophosphate for Injection Sales Market Share by Application (2020-2025)
Table 63. Global Vidarabine Monophosphate for Injection Sales Market Share by Application (2026-2031)
Table 64. Global Vidarabine Monophosphate for Injection Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Vidarabine Monophosphate for Injection Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Vidarabine Monophosphate for Injection Revenue Market Share by Application (2020-2025)
Table 67. Global Vidarabine Monophosphate for Injection Revenue Market Share by Application (2026-2031)
Table 68. Global Vidarabine Monophosphate for Injection Price (US$/Unit) by Application (2020-2025)
Table 69. Global Vidarabine Monophosphate for Injection Price (US$/Unit) by Application (2026-2031)
Table 70. FUREN Group Pharmaceutical Company Information
Table 71. FUREN Group Pharmaceutical Description and Business Overview
Table 72. FUREN Group Pharmaceutical Vidarabine Monophosphate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. FUREN Group Pharmaceutical Vidarabine Monophosphate for Injection Product
Table 74. FUREN Group Pharmaceutical Recent Developments/Updates
Table 75. China Res Double-Crane Company Information
Table 76. China Res Double-Crane Description and Business Overview
Table 77. China Res Double-Crane Vidarabine Monophosphate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. China Res Double-Crane Vidarabine Monophosphate for Injection Product
Table 79. China Res Double-Crane Recent Developments/Updates
Table 80. Kaifeng Mingren Pharmaceutical Company Information
Table 81. Kaifeng Mingren Pharmaceutical Description and Business Overview
Table 82. Kaifeng Mingren Pharmaceutical Vidarabine Monophosphate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Kaifeng Mingren Pharmaceutical Vidarabine Monophosphate for Injection Product
Table 84. Kaifeng Mingren Pharmaceutical Recent Developments/Updates
Table 85. Guangdong Xianqiang Pharmaceutical Company Information
Table 86. Guangdong Xianqiang Pharmaceutical Description and Business Overview
Table 87. Guangdong Xianqiang Pharmaceutical Vidarabine Monophosphate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Guangdong Xianqiang Pharmaceutical Vidarabine Monophosphate for Injection Product
Table 89. Guangdong Xianqiang Pharmaceutical Recent Developments/Updates
Table 90. Hainan Jinrui Pharmaceutical Company Information
Table 91. Hainan Jinrui Pharmaceutical Description and Business Overview
Table 92. Hainan Jinrui Pharmaceutical Vidarabine Monophosphate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Hainan Jinrui Pharmaceutical Vidarabine Monophosphate for Injection Product
Table 94. Hainan Jinrui Pharmaceutical Recent Developments/Updates
Table 95. Haikou Qili Pharmaceutical Company Information
Table 96. Haikou Qili Pharmaceutical Description and Business Overview
Table 97. Haikou Qili Pharmaceutical Vidarabine Monophosphate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Haikou Qili Pharmaceutical Vidarabine Monophosphate for Injection Product
Table 99. Haikou Qili Pharmaceutical Recent Developments/Updates
Table 100. Gansu Changee Bio-pharmaceutical Company Information
Table 101. Gansu Changee Bio-pharmaceutical Description and Business Overview
Table 102. Gansu Changee Bio-pharmaceutical Vidarabine Monophosphate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Gansu Changee Bio-pharmaceutical Vidarabine Monophosphate for Injection Product
Table 104. Gansu Changee Bio-pharmaceutical Recent Developments/Updates
Table 105. Reyoung Pharmaceutical Company Information
Table 106. Reyoung Pharmaceutical Description and Business Overview
Table 107. Reyoung Pharmaceutical Vidarabine Monophosphate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Reyoung Pharmaceutical Vidarabine Monophosphate for Injection Product
Table 109. Reyoung Pharmaceutical Recent Developments/Updates
Table 110. Datong Wuzhou Tong Pharmaceutical Company Information
Table 111. Datong Wuzhou Tong Pharmaceutical Description and Business Overview
Table 112. Datong Wuzhou Tong Pharmaceutical Vidarabine Monophosphate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Datong Wuzhou Tong Pharmaceutical Vidarabine Monophosphate for Injection Product
Table 114. Datong Wuzhou Tong Pharmaceutical Recent Developments/Updates
Table 115. Hainan Huluwa Pharmaceutical Group Company Information
Table 116. Hainan Huluwa Pharmaceutical Group Description and Business Overview
Table 117. Hainan Huluwa Pharmaceutical Group Vidarabine Monophosphate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Hainan Huluwa Pharmaceutical Group Vidarabine Monophosphate for Injection Product
Table 119. Hainan Huluwa Pharmaceutical Group Recent Developments/Updates
Table 120. Guangdong LongFu Medicine Company Information
Table 121. Guangdong LongFu Medicine Description and Business Overview
Table 122. Guangdong LongFu Medicine Vidarabine Monophosphate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Guangdong LongFu Medicine Vidarabine Monophosphate for Injection Product
Table 124. Guangdong LongFu Medicine Recent Developments/Updates
Table 125. Wuhan Hualong Biology Pharmacy Company Information
Table 126. Wuhan Hualong Biology Pharmacy Description and Business Overview
Table 127. Wuhan Hualong Biology Pharmacy Vidarabine Monophosphate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Wuhan Hualong Biology Pharmacy Vidarabine Monophosphate for Injection Product
Table 129. Wuhan Hualong Biology Pharmacy Recent Developments/Updates
Table 130. Sinopharm A-think Pharmaceutical Company Information
Table 131. Sinopharm A-think Pharmaceutical Description and Business Overview
Table 132. Sinopharm A-think Pharmaceutical Vidarabine Monophosphate for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Sinopharm A-think Pharmaceutical Vidarabine Monophosphate for Injection Product
Table 134. Sinopharm A-think Pharmaceutical Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Vidarabine Monophosphate for Injection Distributors List
Table 138. Vidarabine Monophosphate for Injection Customers List
Table 139. Vidarabine Monophosphate for Injection Market Trends
Table 140. Vidarabine Monophosphate for Injection Market Drivers
Table 141. Vidarabine Monophosphate for Injection Market Challenges
Table 142. Vidarabine Monophosphate for Injection Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Vidarabine Monophosphate for Injection
Figure 2. Global Vidarabine Monophosphate for Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Vidarabine Monophosphate for Injection Market Share by Type: 2024 & 2031
Figure 4. 0.1 g/bottle Product Picture
Figure 5. 0.2 g/bottle Product Picture
Figure 6. Global Vidarabine Monophosphate for Injection Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Vidarabine Monophosphate for Injection Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Clinics
Figure 10. Other
Figure 11. Global Vidarabine Monophosphate for Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Vidarabine Monophosphate for Injection Market Size (2020-2031) & (US$ Million)
Figure 13. Global Vidarabine Monophosphate for Injection Sales (2020-2031) & (K Units)
Figure 14. Global Vidarabine Monophosphate for Injection Average Price (US$/Unit) & (2020-2031)
Figure 15. Vidarabine Monophosphate for Injection Report Years Considered
Figure 16. Vidarabine Monophosphate for Injection Sales Share by Manufacturers in 2024
Figure 17. Global Vidarabine Monophosphate for Injection Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Vidarabine Monophosphate for Injection Players: Market Share by Revenue in Vidarabine Monophosphate for Injection in 2024
Figure 19. Vidarabine Monophosphate for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Vidarabine Monophosphate for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Vidarabine Monophosphate for Injection Sales Market Share by Country (2020-2031)
Figure 22. North America Vidarabine Monophosphate for Injection Revenue Market Share by Country (2020-2031)
Figure 23. United States Vidarabine Monophosphate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Vidarabine Monophosphate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Vidarabine Monophosphate for Injection Sales Market Share by Country (2020-2031)
Figure 26. Europe Vidarabine Monophosphate for Injection Revenue Market Share by Country (2020-2031)
Figure 27. Germany Vidarabine Monophosphate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Vidarabine Monophosphate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Vidarabine Monophosphate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Vidarabine Monophosphate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Vidarabine Monophosphate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Vidarabine Monophosphate for Injection Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Vidarabine Monophosphate for Injection Revenue Market Share by Region (2020-2031)
Figure 34. China Vidarabine Monophosphate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Vidarabine Monophosphate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Vidarabine Monophosphate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Vidarabine Monophosphate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Vidarabine Monophosphate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Vidarabine Monophosphate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Vidarabine Monophosphate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Vidarabine Monophosphate for Injection Sales Market Share by Country (2020-2031)
Figure 42. Latin America Vidarabine Monophosphate for Injection Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Vidarabine Monophosphate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Vidarabine Monophosphate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Vidarabine Monophosphate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Vidarabine Monophosphate for Injection Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Vidarabine Monophosphate for Injection Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Vidarabine Monophosphate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Vidarabine Monophosphate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Vidarabine Monophosphate for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Vidarabine Monophosphate for Injection by Type (2020-2031)
Figure 52. Global Revenue Market Share of Vidarabine Monophosphate for Injection by Type (2020-2031)
Figure 53. Global Vidarabine Monophosphate for Injection Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Vidarabine Monophosphate for Injection by Application (2020-2031)
Figure 55. Global Revenue Market Share of Vidarabine Monophosphate for Injection by Application (2020-2031)
Figure 56. Global Vidarabine Monophosphate for Injection Price (US$/Unit) by Application (2020-2031)
Figure 57. Vidarabine Monophosphate for Injection Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
